Related Experiment Video

Updated: May 3, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

6.6K

Dickkopf-1 as a mediator and novel target in malignant bone disease

Tilman D Rachner1, Andy Göbel1, Peggy Benad-Mehner1

  • 1Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technical University, Dresden, Germany.

Cancer Letters
|January 28, 2014
PubMed

Insights

Dickkopf-1 (DKK1) is implicated in malignant bone disease by hindering bone formation. Targeting DKK1 presents a promising therapeutic strategy for bone metastases in cancers like myeloma, breast, and prostate cancer.

Area of Science:

  • Oncology
  • Bone Biology
  • Metastasis Research

Background:

  • Bone metastases are a frequent complication in myeloma, breast, and prostate cancers.
  • The Wnt signaling pathway inhibitor Dickkopf-1 (DKK1) plays a role in bone lesion development.
  • DKK1 impairs osteoblast activity, crucial for bone health.

Purpose of the Study:

  • To review the role of Dickkopf-1 in mediating malignant bone disease.
  • To explore Dickkopf-1 as a potential therapeutic target for bone metastases.

Main Methods:

  • Literature review of studies on Dickkopf-1 and bone metastases.
  • Analysis of DKK1's mechanism in bone lesion formation.
  • Discussion of therapeutic strategies targeting DKK1.

Main Results:

  • Dickkopf-1 is a key mediator in the pathogenesis of bone metastases.
  • Inhibition of osteoblast function by DKK1 contributes to bone destruction.
  • Evidence suggests DKK1 is a viable therapeutic target.

Conclusions:

  • Dickkopf-1 is a significant factor in the progression of bone metastases.
  • Targeting Dickkopf-1 offers a novel therapeutic avenue for managing bone lesions in cancer patients.
Keywords:
Dickkopf-1Malignant bone diseaseWNT signaling

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K
Osteoclast Derivation from Mouse Bone Marrow06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

23.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K